Inhibiting Thrombopoietin Receptor (TPO-R) Signaling as a Novel Approach to Target TET2 Mutation-Driven Clonal Hematopoiesis
Inhibiting Thrombopoietin Receptor (TPO-R) Signaling as a Novel Approach to Target TET2 Mutation-Driven Clonal Hematopoiesis
批准号:
483332
负责人:
Chan Steven M
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-03-01 至 2024-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Clonal Hematopoiesis of Indeterminate Potential (CHIP) refers to the presence of blood cells carrying mutations associated with leukemia in individuals without evidence of a blood disorder. Individuals with CHIP are at a substantially higher risk of devel
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibiting Thrombopoietin Receptor (TPO-R) Signaling as a Novel Approach to Target TET2 Mutation-Driven Clonal Hematopoiesis
-
批准号:489650
-
项目类别:Operating Grants
-
资助金额:$29.82万
-
财政年份:2023
-
负责人:Chan Steven M
-
依托单位:
Role of Thrombopoietin Receptor (TPO-R) Signaling in TET2 Mutation-Driven Clonal Hematopoiesis
-
批准号:472513
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Chan Steven M
-
依托单位:
Repurposing Metformin to Target TET2 Mutation Driven Clonal Hematopoiesis and Malignant Transformation
-
批准号:434508
-
项目类别:Operating Grants
-
资助金额:$41.8万
-
财政年份:2020
-
负责人:Chan Steven M
-
依托单位:
PINK1 Inhibition as a Novel Therapeutic Strategy to Target Acute Myeloid Leukemia Stem Cells
-
批准号:380799
-
项目类别:Operating Grants
-
资助金额:$25.36万
-
财政年份:2018
-
负责人:Chan Steven M
-
依托单位:
海外基金